Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting metastasis
Patricia S. Steeg
Nature reviews. Cancer (2016) Vol. 16, Iss. 4, pp. 201-218
Open Access | Times Cited: 1223

Showing 1-25 of 1223 citing articles:

Emerging Biological Principles of Metastasis
Arthur W. Lambert, Diwakar R. Pattabiraman, Robert A. Weinberg
Cell (2017) Vol. 168, Iss. 4, pp. 670-691
Open Access | Times Cited: 2652
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares, Mohamad Y. Fares, Hussein H. Khachfe, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 1782
ROS in cancer therapy: the bright side of the moon
Bruno Perillo, Marzia Di Donato, Antonio Pezone, et al.
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 2, pp. 192-203
Open Access | Times Cited: 1715
Nanotechnology for Multimodal Synergistic Cancer Therapy
Wenpei Fan, Bryant C. Yung, Peng Huang, et al.
Chemical Reviews (2017) Vol. 117, Iss. 22, pp. 13566-13638
Closed Access | Times Cited: 1587
Pre-metastatic niches: organ-specific homes for metastases
Héctor Peinado, Haiying Zhang, Irina Matei, et al.
Nature reviews. Cancer (2017) Vol. 17, Iss. 5, pp. 302-317
Closed Access | Times Cited: 1528
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
María Reig, Zoe Mariñó, Christie Perelló, et al.
Journal of Hepatology (2016) Vol. 65, Iss. 4, pp. 719-726
Open Access | Times Cited: 981
Integrative clinical genomics of metastatic cancer
Dan R. Robinson, Yi-Mi Wu, Robert J. Lonigro, et al.
Nature (2017) Vol. 548, Iss. 7667, pp. 297-303
Open Access | Times Cited: 808
The metabolism of cancer cells during metastasis
Gabriele Bergers, Sarah‐Maria Fendt
Nature reviews. Cancer (2021) Vol. 21, Iss. 3, pp. 162-180
Open Access | Times Cited: 665
Control of Metastasis by NK Cells
Alejandro López‐Soto, Segundo González, Mark J. Smyth, et al.
Cancer Cell (2017) Vol. 32, Iss. 2, pp. 135-154
Open Access | Times Cited: 645
Defining the Hallmarks of Metastasis
Danny R. Welch, Douglas R. Hurst
Cancer Research (2019) Vol. 79, Iss. 12, pp. 3011-3027
Open Access | Times Cited: 577
Cancer cell motility: lessons from migration in confined spaces
Colin D. Paul, Panagiotis Mistriotis, Κωνσταντίνος Κωνσταντόπουλος
Nature reviews. Cancer (2016) Vol. 17, Iss. 2, pp. 131-140
Open Access | Times Cited: 571
Cell motility in cancer invasion and metastasis: insights from simple model organisms
Christina H. Stuelten, Carole A. Parent, Denise J. Montell
Nature reviews. Cancer (2018) Vol. 18, Iss. 5, pp. 296-312
Open Access | Times Cited: 458
Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research
Xuhui Tong, Rong Tang, Mingming Xiao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 457
EMT, cancer stem cells and autophagy; The three main axes of metastasis
Ghader Babaei, Shiva Gholizadeh‐Ghaleh Aziz, Nasrin Zare Zavieyh Jaghi
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110909-110909
Open Access | Times Cited: 395
Magnetic Targeting, Tumor Microenvironment-Responsive Intelligent Nanocatalysts for Enhanced Tumor Ablation
Lili Feng, Rui Xie, Chuanqing Wang, et al.
ACS Nano (2018) Vol. 12, Iss. 11, pp. 11000-11012
Closed Access | Times Cited: 394
Intravascular Survival and Extravasation of Tumor Cells
Boris Strilić, Stefan Offermanns
Cancer Cell (2017) Vol. 32, Iss. 3, pp. 282-293
Open Access | Times Cited: 346
Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
K. Myers, Sarah R. Amend, Kenneth J. Pienta
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 331
Brain malignancies: Glioblastoma and brain metastases
Tamara T. Lah, Metka Novak, Barbara Breznik
Seminars in Cancer Biology (2019) Vol. 60, pp. 262-273
Open Access | Times Cited: 322
Migrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges
Aneta Gandalovičová, Daniel Rösel, Michael Fernandes, et al.
Trends in cancer (2017) Vol. 3, Iss. 6, pp. 391-406
Open Access | Times Cited: 312
Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
Hai Wang, Zan Gao, Xuanyou Liu, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 292
Epigenetic therapy inhibits metastases by disrupting premetastatic niches
Zhihao Lü, Jianling Zou, Shuang Li, et al.
Nature (2020) Vol. 579, Iss. 7798, pp. 284-290
Open Access | Times Cited: 284
A framework for the development of effective anti-metastatic agents
Robin L. Anderson, Theo Balasas, Juliana Callaghan, et al.
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 185-204
Open Access | Times Cited: 280
Au2Pt-PEG-Ce6 nanoformulation with dual nanozyme activities for synergistic chemodynamic therapy / phototherapy
Man Wang, Mengyu Chang, Qing Chen, et al.
Biomaterials (2020) Vol. 252, pp. 120093-120093
Closed Access | Times Cited: 266
Mouse models of metastasis: progress and prospects
Laura Gómez-Cuadrado, Natasha Tracey, Ruoyu Ma, et al.
Disease Models & Mechanisms (2017) Vol. 10, Iss. 9, pp. 1061-1074
Open Access | Times Cited: 265
Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche
Michael P. Plebanek, Nicholas L. Angeloni, Elena Vinokour, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 265
Page 1 - Next Page

Scroll to top